AGYTF:OTC-Allergy Therapeutics plc (USD)

COMMON STOCK | Drug Manufacturers - Major |

Last Closing

USD 0.02

Change

0.00 (0.00)%

Market Cap

USD 0.08B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Drug Manufacturers - Major

ETFs Containing AGYTF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Major) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 100.00% 100% F 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.00% 100% F 94% A
Trailing 12 Months  
Capital Gain -60.00% 100% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.00% 100% F 19% F
Trailing 5 Years  
Capital Gain -88.24% 100% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.24% 100% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 7,163.51% 100% F 99% N/A
Dividend Return 7,163.51% 100% F 99% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41,061.81% 100% F 1% F
Risk Adjusted Return 17.45% 100% F 52% F
Market Capitalization 0.08B 100% F 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.